A 'one-stop-shop'point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: the PIVOT study
Y Sheehan, EB Cunningham, A Cochrane, M Byrne… - Journal of …, 2023 - Elsevier
Background & Aims Prisons are key venues for scaling-up hepatitis C virus (HCV) testing
and treatment. Complex clinical pathways and frequent movements of people in prison …
and treatment. Complex clinical pathways and frequent movements of people in prison …
Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden
K Lindqvist, Z Thorin, M Kåberg - Harm Reduction Journal, 2023 - Springer
Background People who inject drugs (PWID) represent a population with an increased
prevalence of hepatitis C (HCV) infections. HCV treatment among PWID is essential to reach …
prevalence of hepatitis C (HCV) infections. HCV treatment among PWID is essential to reach …
[HTML][HTML] Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study
KB Malme, K Ulstein, AK Finbråten… - International Journal of …, 2023 - Elsevier
Background Improving HCV treatment uptake among people who inject drugs (PWID) is
crucial to achieving the WHO elimination targets. The aims were to evaluate HCV treatment …
crucial to achieving the WHO elimination targets. The aims were to evaluate HCV treatment …
Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who …
EJ Austin, AJ Gojic, EP Bhatraju, KA Pierce… - International Journal of …, 2023 - Elsevier
Abstract Background Direct-acting antivirals (DAAs) offer an unprecedented opportunity to
eliminate hepatitis C virus (HCV) infection, yet barriers among people who inject drugs …
eliminate hepatitis C virus (HCV) infection, yet barriers among people who inject drugs …
A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the “ …
MC Herink, A Seaman, G Leichtling, JE Larsen… - Addiction Science & …, 2023 - Springer
Abstract Background Hepatitis C virus (HCV) transmission is primarily driven by injection
drug use, and acute HCV infection rates are increased in rural communities with substantial …
drug use, and acute HCV infection rates are increased in rural communities with substantial …
[HTML][HTML] Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study
B Maasoumy, P Ingiliz, CD Spinner, C Cordes… - JHEP Reports, 2023 - Elsevier
Background & Aims EASL guidelines recommend 8 weeks of treatment with sofosbuvir plus
velpatasvir (SOF/VEL) for the treatment of acute or recently acquired HCV infection, but only …
velpatasvir (SOF/VEL) for the treatment of acute or recently acquired HCV infection, but only …
[HTML][HTML] The path to hepatitis C elimination: who are we leaving behind and why?
JK Rockstroh, T Swan, J Chang… - Journal of the …, 2023 - ncbi.nlm.nih.gov
The 2016 World Health Organization (WHO) 2030 global elimination targets for hepatitis C
virus (HCV) are: 80% of those with chronic HCV treated, 90% reduction in incidence and …
virus (HCV) are: 80% of those with chronic HCV treated, 90% reduction in incidence and …
A community-based strategy to eliminate hepatitis C among people who inject drugs in Vietnam
Background Towards hepatitis C elimination among people who inject drugs (PWID), we
assessed the effectiveness of a strategy consisting of a community-based respondent-driven …
assessed the effectiveness of a strategy consisting of a community-based respondent-driven …
[HTML][HTML] A video-observed treatment strategy to improve adherence to treatment among persons who inject drugs infected with hepatitis C virus: qualitative study of …
A Karasz, K Merchant, J Arnsten, J Feinberg… - Journal of medical …, 2023 - jmir.org
Background Direct-acting antiviral medications have the potential to eliminate the hepatitis C
virus (HCV) epidemic among people who inject drugs; yet, suboptimal adherence remains a …
virus (HCV) epidemic among people who inject drugs; yet, suboptimal adherence remains a …